• No results found

Ten-Year Results From a Phase II Study on Image Guided, Intensity Modulated Radiation Therapy With Simultaneous Integrated Boost in High-Risk Prostate Cancer

N/A
N/A
Protected

Academic year: 2022

Share "Ten-Year Results From a Phase II Study on Image Guided, Intensity Modulated Radiation Therapy With Simultaneous Integrated Boost in High-Risk Prostate Cancer"

Copied!
8
0
0

Laster.... (Se fulltekst nå)

Fulltekst

Referanser

RELATERTE DOKUMENTER

Adding abiraterone for men with high-risk prostate cancer (PCa) starting long-term androgen deprivation therapy (ADT): Survival results from STAMPEDE (NCT00268476).. Tidsskr

Increased risk of biochemical and local failure in patients with distended rectum on the planning CT for prostate cancer radiotherapy... Conformal arc radiotherapy for prostate

Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo- controlled,

Increased risk of biochemical and local failure in patients with distended rectum on the planning CT for prostate cancer radiotherapy... Conformal arc radiotherapy for prostate

(2011) A randomized, double-blind phase III study of icotinib versus gefitinib in patients with advanced non-small cell lung cancer (NSCLC) previously treated with

Reduction in median waiting times for radiotherapy among colorectal, lung and prostate cancer patients 11.. ranged from

The survival benefit of dose-escalation with High-Dose-Rate brachytherapy (HDR-BT) combined with External Beam Radiotherapy (EBRT) for the treatment of high-risk prostate cancer

Adding abiraterone for men with high-risk prostate cancer (PCa) starting long-term androgen deprivation therapy (ADT): Survival results from STAMPEDE (NCT00268476).. Tidsskr